Effects of Automatic Deep-Learning-Based Lung Analysis on Quantification of Interstitial Lung Disease: Correlation with Pulmonary Function Test Results and Prognosis
Abstract:We investigated the feasibility of a new deep-learning (DL)-based lung analysis method for the evaluation of interstitial lung disease (ILD) by comparing it with evaluation using the traditional computer-aided diagnosis (CAD) system and patients’ clinical outcomes. We prospectively included 104 patients (84 with and 20 without ILD). An expert radiologist defined regions of interest in the typical areas of normal, ground-glass opacity, consolidation, consolidation with fibrosis (traction bronchiectasis), honeyc… Show more
“…However, in ILD, a simple density mask approach cannot effectively distinguish the lung from the chest wall due to lesions with high attenuation, such as consolidation and fibrosis [ 90 ]. Therefore, it is recommended to employ dedicated software for the automatic segmentation of the lung, as mentioned above [ 78 , 82 , 85 , 91 ].…”
Section: Ct Analysis Of Ildmentioning
confidence: 99%
“…The BV5% value, calculated as the proportion of BV5 to total BV, was found to be a prognostic factor for adverse outcomes (intubation or mortality) in patients with COVID-19 [ 139 ]. In thin-section CT scans of COVID-19 pneumonia, bilateral distribution and subsegmental vessel enlargement are usually observed in clinical situations [ 85 , 140 , 141 ]. These vascular abnormalities are consistent with the results of dual-energy CT [ 142 , 143 ] and microvascular observations using video microscopy [ 143 ].…”
Section: Thin-section Ct Analysis For Covid-19 Pneumoniamentioning
Thin-section computed tomography (CT) is widely employed not only for assessing morphology but also for evaluating respiratory function. Three-dimensional images obtained from thin-section CT provide precise measurements of lung, airway, and vessel volumes. These volumetric indices are correlated with traditional pulmonary function tests (PFT). CT also generates lung histograms. The volume ratio of areas with low and high attenuation correlates with PFT results. These quantitative image analyses have been utilized to investigate the early stages and disease progression of diffuse lung diseases, leading to the development of novel concepts such as pre-chronic obstructive pulmonary disease (pre-COPD) and interstitial lung abnormalities. Quantitative analysis proved particularly valuable during the COVID-19 pandemic when clinical evaluations were limited. In this review, we introduce CT analysis methods and explore their clinical applications in the context of various lung diseases. We also highlight technological advances, including images with matrices of 1024 × 1024 and slice thicknesses of 0.25 mm, which enhance the accuracy of these analyses.
“…However, in ILD, a simple density mask approach cannot effectively distinguish the lung from the chest wall due to lesions with high attenuation, such as consolidation and fibrosis [ 90 ]. Therefore, it is recommended to employ dedicated software for the automatic segmentation of the lung, as mentioned above [ 78 , 82 , 85 , 91 ].…”
Section: Ct Analysis Of Ildmentioning
confidence: 99%
“…The BV5% value, calculated as the proportion of BV5 to total BV, was found to be a prognostic factor for adverse outcomes (intubation or mortality) in patients with COVID-19 [ 139 ]. In thin-section CT scans of COVID-19 pneumonia, bilateral distribution and subsegmental vessel enlargement are usually observed in clinical situations [ 85 , 140 , 141 ]. These vascular abnormalities are consistent with the results of dual-energy CT [ 142 , 143 ] and microvascular observations using video microscopy [ 143 ].…”
Section: Thin-section Ct Analysis For Covid-19 Pneumoniamentioning
Thin-section computed tomography (CT) is widely employed not only for assessing morphology but also for evaluating respiratory function. Three-dimensional images obtained from thin-section CT provide precise measurements of lung, airway, and vessel volumes. These volumetric indices are correlated with traditional pulmonary function tests (PFT). CT also generates lung histograms. The volume ratio of areas with low and high attenuation correlates with PFT results. These quantitative image analyses have been utilized to investigate the early stages and disease progression of diffuse lung diseases, leading to the development of novel concepts such as pre-chronic obstructive pulmonary disease (pre-COPD) and interstitial lung abnormalities. Quantitative analysis proved particularly valuable during the COVID-19 pandemic when clinical evaluations were limited. In this review, we introduce CT analysis methods and explore their clinical applications in the context of various lung diseases. We also highlight technological advances, including images with matrices of 1024 × 1024 and slice thicknesses of 0.25 mm, which enhance the accuracy of these analyses.
“…Additionally, regarding the risk of malignancy development or coexistence, in a recent study of Liang et al, it is mentioned that whole-lung CT texture analysis is a promising tool for the lung cancer risk stratification of IPF patients [ 32 ]. Moreover, Aoki et al [ 33 ] using deep-learning-based analysis and measured consolidation with fibrosis, found that it was independently associated with poor survival. They also found that the lesion extent measured using deep-learning-based analysis showed a negative correlation with pulmonary function test results and prognosis.…”
Section: Ai Applications In Ild Researchmentioning
confidence: 99%
“…A summarizing table (Table 1) for the included studies has been added at the end of this section. [30] Prognosis 465 patients Imaging -Budzikowski et al [31] Prognosis 169 patients Imaging and Genomic -Liang et al [32] Prognosis 116 patients Imaging AUC = 0.870 Aoki et al [33] Prognosis 104 patients Imaging -Bowman et al [34] Prognosis 589 patients Proteomic Sensitivity: 90% Mayr et al [35] Prognosis 124 patients Proteomic Accuracy: 83%…”
Section: Ai Applications In Ild Researchmentioning
Interstitial lung diseases (ILDs) comprise a rather heterogeneous group of diseases varying in pathophysiology, presentation, epidemiology, diagnosis, treatment and prognosis. Even though they have been recognized for several years, there are still areas of research debate. In the majority of ILDs, imaging modalities and especially high-resolution Computed Tomography (CT) scans have been the cornerstone in patient diagnostic approach and follow-up. The intricate nature of ILDs and the accompanying data have led to an increasing adoption of artificial intelligence (AI) techniques, primarily on imaging data but also in genetic data, spirometry and lung diffusion, among others. In this literature review, we describe the most prominent applications of AI in ILDs presented approximately within the last five years. We roughly stratify these studies in three categories, namely: (i) screening, (ii) diagnosis and classification, (iii) prognosis.
“…AI-based image analysis has advantages in terms of high reliability and reproducibility over other methods. Furthermore, indices derived from AI-based image analysis have been associated with pulmonary function decline, exacerbation, and prognosis in ILD [11][12][13]. Artificial intelligence based quantitative CT image analysis software (AIQCT) is an AI-based image analysis software that can automatically classify chest CT images into normal lung, ground-glass opacities (GGOs), reticulations, consolidations, honeycombing, nodules, hyperlucencies, interlobular septum, bronchi, and vessels [14].…”
Background
Interstitial lung abnormalities (ILAs) on CT may affect the clinical outcomes in patients with chronic obstructive pulmonary disease (COPD), but their quantification remains unestablished. This study examined whether artificial intelligence (AI)-based segmentation could be applied to identify ILAs using two COPD cohorts.
Methods
ILAs were diagnosed visually based on the Fleischner Society definition. Using an AI-based method, ground-glass opacities, reticulations, and honeycombing were segmented, and their volumes were summed to obtain the percentage ratio of interstitial lung disease-associated volume to total lung volume (ILDvol%). The optimal ILDvol% threshold for ILA detection was determined in cross-sectional data of the discovery and validation cohorts. The 5-year longitudinal changes in ILDvol% were calculated in discovery cohort patients who underwent baseline and follow-up CT scans.
Results
ILAs were found in 32 (14%) and 15 (10%) patients with COPD in the discovery (n = 234) and validation (n = 153) cohorts, respectively. ILDvol% was higher in patients with ILAs than in those without ILA in both cohorts. The optimal ILDvol% threshold in the discovery cohort was 1.203%, and good sensitivity and specificity (93.3% and 76.3%) were confirmed in the validation cohort. 124 patients took follow-up CT scan during 5 ± 1 years. 8 out of 124 patients (7%) developed ILAs. In a multivariable model, an increase in ILDvol% was associated with ILA development after adjusting for age, sex, BMI, and smoking exposure.
Conclusion
AI-based CT quantification of ILDvol% may be a reproducible method for identifying and monitoring ILAs in patients with COPD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.